Research progress on the pathogenesis of the SDHB mutation and related diseases

Biomed Pharmacother. 2023 Nov:167:115500. doi: 10.1016/j.biopha.2023.115500. Epub 2023 Sep 19.

Abstract

With the improvement of genetic testing technology in diseases in recent years, researchers have a more detailed and clear understanding of the source of cancers. Succinate dehydrogenase B (SDHB), a mitochondrial gene, is related to the metabolic activities of cells and tissues throughout the body. The mutations of SDHB have been found in pheochromocytoma, paraganglioma and other cancers, and is proved to affect the occurrence and progress of those cancers due to the important structural functions. The importance of SDHB is attracting more and more attention of researchers, however, reviews on the structure and function of SDHB, as well as on the mechanism of its carcinogenesis is inadequate. This paper reviews the relationship between SDHB mutations and related cancers, discusses the molecular mechanism of SDHB mutations that may lead to tumor formation, analyzes the mutation spectrum, structural domains, and penetrance of SDHB and sorts out some of the previously discovered diseases. For the patients with SDHB mutation, it is recommended that people in SDHB mutation families undergo regular genetic testing or SDHB immunohistochemistry (IHC). The purpose of this paper is hopefully to provide some reference and help for follow-up researches on SDHB.

Keywords: Mitochondrial gene; Paraganglioma; Pheochromocytoma; SDHB mutation; Tumor genetics.

Publication types

  • Review

MeSH terms

  • Adrenal Gland Neoplasms* / genetics
  • Germ-Line Mutation / genetics
  • Humans
  • Mutation / genetics
  • Paraganglioma* / genetics
  • Paraganglioma* / pathology
  • Pheochromocytoma* / genetics
  • Pheochromocytoma* / pathology
  • Succinate Dehydrogenase / genetics

Substances

  • Succinate Dehydrogenase
  • SDHB protein, human